期刊文献+

基质金属蛋白酶9在中耳胆脂瘤上皮中的表达及其与骨质破坏关系的研究 被引量:1

The expression of matrix metalloproteinase-9 and its relationship with bone destruction in cholesteatoma
下载PDF
导出
摘要 目的:探讨基质金属蛋白酶9(MMP-9)在胆脂瘤上皮中的表达及其与胆脂瘤骨质破坏之间的关系。方法:取我院住院手术患者22例的胆脂瘤上皮,外耳道正常皮肤组织作对照,分别用免疫组化的方法测定MMP-9的表达,并利用计算机图像分析系统进行分析。结果:MMP-9在中耳胆脂瘤上皮组织及外耳道深部正常皮肤均有表达,平均光密度值分别为:0.263±0.013和0.221±0.006,经统计学分析显示中耳胆脂瘤上皮组织中的含量显著高于外耳道深部正常皮肤(P<0.05),且与骨质破坏的程度相关(r=0.9626)。结论:MMP-9与中耳胆脂瘤的骨质破坏密切相关,是中耳胆脂瘤骨质破坏中的很重要的物质。 Objective: To study the expression of matrix metalloproteinase-9 and its relationship with bone destruction in cholesteatoma.Methods: Took 22 cholesteatoma tissues as the sample and normal auditory meatal skin as a control,the samples were examined immunohistochemically,MMP-9 were detected with immunohistochemical(SP method),observed under microscope and send the image to a computer,the gray-scale of positive signals were measured by computer image processing technology.Results: The expression of MMP-9 in cholesteatoma was 0.263±0.013,and that in normal auditory meatal skin was 0.221±0.006.It showed statistically significant difference(P0.05).The expression of MMP-9 was related with bone destruction in cholesteatoma(r=0.9626).Conclusion: MMP-9 in the middle ear cholesteatoma tissue showed higher expression,MMP-9 was related with bone destruction in cholesteatoma,and its expression has positive correlation to the degree of bone destruction.
出处 《南通大学学报(医学版)》 2012年第2期123-125,共3页 Journal of Nantong University(Medical sciences)
关键词 胆脂瘤 中耳炎 骨质破坏 基质金属蛋白酶9 cholesteatoma otitis media bone destruction matrix metalloproteinase-9
  • 相关文献

参考文献10

  • 1林刃舆,迟放鲁,陈必成,陈建福,李智渊,王培基.EGFR和磷酸化酪氨酸在中耳胆脂瘤的表达情况[J].中国眼耳鼻喉科杂志,2003,3(1):1-4. 被引量:13
  • 2Marenda SA,Aufdemorte TB.Localization of cytokines incholesteatoma tissue[J].Otolaryngol Head Neck Surg,1995,112(3):359-368.
  • 3Park HJ,Park K.Expression of Fas/APO-1 and apoptosisof keratinocytes in human cholesteatoma[J].Laryngoscope,1999,109(4):613-616.
  • 4Shinoda H,Huang CC.Expressions of c-jun and p53 pro-teins in human middle ear cholesteatoma:relationship tokeratinocyte proliferation,differentiation,and programmedcell death[J].Laryngoscope,1995,105(11):1232-1237.
  • 5林刃舆,迟放鲁.中耳胆脂瘤形成机理的研究进展[J].国外医学(耳鼻咽喉科学分册),2001,25(3):153-156. 被引量:17
  • 6江超武,展鸿谋,王文惠,张林,金树珍,杨一兵,章宗籍.转化生长因子β1和即刻早期基因及p27在中耳胆脂瘤上皮中的表达[J].中华耳鼻咽喉科杂志,2004,39(4):211-215. 被引量:16
  • 7Kleiner DE,Stetler-Stevenson WG.Matrix metallopro-teinases and metastasis[J].Cancer Chemother Pharmacol,1999,43 Suppl:S42-S51.
  • 8徐志文,倪海峰.胆脂瘤型中耳炎骨质破坏机制及手术治疗[J].国外医学(耳鼻咽喉科学分册),2005,29(4):251-254. 被引量:10
  • 9Wilmoth JG,Schultz GS,Antonelli PJ.Matrix metallopro-teinases in a gerbil cholesteatoma model[J].OtolaryngolHead Neck Surg,2003,129(4):402-407.
  • 10Juhsz A,Szikli I,Rakosy Z,et al.Elevated level oftenascin and matrix metalloproteinase 9 correlates withthe bone destruction capacity of cholesteatomas[J].OtolNeurotol,2009,30(4):559-565.

二级参考文献60

  • 1张武宁,唐安洲,徐志文,谭颂华.慢性化脓性中耳炎的咽鼓管功能对手术疗效的影响[J].中华耳科学杂志,2004,2(2):114-118. 被引量:9
  • 2孙文忠,徐志文,唐安洲,苏纪平.PTKs CDK4及p15在中耳胆脂瘤上皮的表达[J].临床耳鼻咽喉科杂志,2004,18(10):616-619. 被引量:7
  • 3王辉兵,徐志文,唐安洲,苏纪平.中耳胆脂瘤基质金属蛋白酶2,9的活性检测及临床意义[J].临床耳鼻咽喉科杂志,2004,18(10):620-622. 被引量:14
  • 4李厚恩,汪磊.表皮生长因子受体在胆脂瘤的异常表达[J].耳鼻咽喉(头颈外科),1996,3(4):195-198. 被引量:3
  • 5Shieh TJ,Ho KY,Kuo WR,et al.Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.Kaohsiung J Med Sci,1999,15:468-474.
  • 6Shiwa M,Kojima H,Moriyama H.Expression of transferming growth factor-alpha in cholesteatoma.J Laryngol Otol,1998,112:750-774.
  • 7Tanaka Y,Kojima H,Miyazaki H,et al.Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.Laryngoscope,1999,109(7 pt 1):1102-1107.
  • 8Sastry KV,Sharma C,Mann SB,et al.Aural cholesteatoma: Role of tumor necrosis factor-a in bone destruction.Am J Otol,1999,20:158-161.
  • 9Koto A,Ohashi Y,Masamoto H,et al.Interleukin-6 and tumor necrosis factor-alpha synthesize by cholesteatoma cells affect munociliary function in the Eustachian tube.Acta Otolaryngol Suppl,1998,53:890-897.
  • 10Milewski C,Fedorowski A,Stan AC,et al.Basic fibroblast growth factor b-TGF in the perimatrix of cholesteatoma.HNO,1998,46:804-808.

共引文献46

同被引文献10

  • 1李楠,秦兆冰,董明敏.基质金属蛋白酶-9和肿瘤坏死因子-α在中耳胆脂瘤中的表达[J].临床耳鼻咽喉科杂志,2004,18(7):424-426. 被引量:6
  • 2Saleh HA, Mills RP. Classification and staging of cholesteatoma. Clin OtolaryngolAIlied Sci, 1999, 24: 355- 359.
  • 3Akimoto R, Pawankar R, Yagi T, et al. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-I, interleukin-1- alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec, 2000, 62: 257-265.
  • 4Hotokezaka H, Sakai E, Ohara N, et al. Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha Iipopolysaceharide, or peptidoglycan. J Cell Biochem, 2007, 101 : 122-134.
  • 5Shirazi MA, Muzaffar K, Leonetti JP, et al. Surgical treatment of pediatric cholesteatomas. Laryngoscope, 2006, 116: 1603-1607.
  • 6AlvesAL, Pereira CS, Ribeiro FdeA, et al. Analysis of histopathological aspects in acquired middle ear cholesteatoma. BrazJOtorhinolaryngol, 2008, 74: 835-841.
  • 7Dornelles Cde C, da Costa SS, Meurer L, et al. Comparison of acquired cholesteatoma between pediatric and adult patients. EurArch Otorhinolaryngol, 2009, 266: 1553-1561.
  • 8Vartiainen E, Nuutinen J. Long-term results of surgery for childhood cholesteatoma. Int J Pediatr Otorhinolaryngol, 1992, 24: 201-208.
  • 9叶放蕾,朱丽雅,崔艳红,郝少娟.MMP-9在中耳胆脂瘤中的表达和意义[J].听力学及言语疾病杂志,2008,16(5):412-414. 被引量:2
  • 10柯嘉,马芙蓉,杜晨,潘滔,张珂.儿童及青少年慢性化脓性中耳炎临床特点[J].中国耳鼻咽喉头颈外科,2011,18(7):342-344. 被引量:16

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部